These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 5271970)

  • 1. Cycloserine in the treatment of pulmonary tuberculosis.
    Bumbacescu N
    Scand J Respir Dis Suppl; 1970; 71():115-9. PubMed ID: 5271970
    [No Abstract]   [Full Text] [Related]  

  • 2. Cycloserine in the treatment of pulmonary tuberculosis.
    Aceves Ortega R; Cortés de la Peña F; Sanchez Ceceña S; Arreola Chavez C
    Scand J Respir Dis Suppl; 1970; 71():109-14. PubMed ID: 5271969
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical experience with cycloserine in Hungary.
    Kováts F
    Scand J Respir Dis Suppl; 1970; 71():133-8. PubMed ID: 5271973
    [No Abstract]   [Full Text] [Related]  

  • 4. Evaluation of cycloserine as an antituberculous drug.
    Gomi J
    Scand J Respir Dis Suppl; 1970; 71():130-2. PubMed ID: 5317742
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of chronic destructive forms of pulmonary tuberculosis with drugs of the second series in different combinations].
    Mamolat AS; Bialik IB
    Probl Tuberk; 1969; 47(6):23-8. PubMed ID: 4311969
    [No Abstract]   [Full Text] [Related]  

  • 6. Results of treatment of patients with pulmonary tuberculous with a combination of cycloserine and other tuberculostatics.
    Raboukhine A
    Scand J Respir Dis Suppl; 1970; 71():155-8. PubMed ID: 5271977
    [No Abstract]   [Full Text] [Related]  

  • 7. [Restoration of drug sensitivity in Mycobacterium tuberculosis to streptomycin and isoniazid during treatment with preparations of the 1st series].
    Rudoĭ NM; Utkin VV; Fedorova IE; Afanas'eva IuP
    Antibiotiki; 1970 Apr; 15(4):355-7. PubMed ID: 4993044
    [No Abstract]   [Full Text] [Related]  

  • 8. [The problem of infectiousness of tuberculosis patients during chemotherapy].
    Schulthess HK; Zollikofer H
    Schweiz Med Wochenschr; 1981 Feb; 111(8):251-4. PubMed ID: 6785880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effectiveness of the agents of the 2d series in treating patients with chronic destructive tuberculosis of the lungs].
    Utkin VV
    Probl Tuberk; 1973; 51(1):12-6. PubMed ID: 4727151
    [No Abstract]   [Full Text] [Related]  

  • 10. Position of cycloserine in the treatment of pulmonary tuberculosis.
    Meyer A; Nadjar G
    Scand J Respir Dis Suppl; 1970; 71():139-43. PubMed ID: 5271974
    [No Abstract]   [Full Text] [Related]  

  • 11. Limitations of the clinical activity of cycloserine therapy. Appearance of resistance to cycloserine when used alone and in combination with other drugs.
    Molina C
    Scand J Respir Dis Suppl; 1970; 71():296-305. PubMed ID: 5272000
    [No Abstract]   [Full Text] [Related]  

  • 12. [On the lability of the degree of drug resistance of Mycobacterium tuberculosis strains].
    Belogurova VP
    Antibiotiki; 1967 Aug; 12(8):718-22. PubMed ID: 4968418
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical activity of cycloserine in the treatment of pulmonary tuberculosis.
    Jimenez M
    Scand J Respir Dis Suppl; 1970; 71():172-3. PubMed ID: 5271980
    [No Abstract]   [Full Text] [Related]  

  • 14. [Possibilities and limitations of multiple chemoantibiotics in treatment of chronic pulmonary tuberculosis].
    Zanotelli F; Perusi O
    G Ital Mal Torace; 1966; 20(6):365-78. PubMed ID: 5997781
    [No Abstract]   [Full Text] [Related]  

  • 15. [Improved therapy of tuberculosis with a well tolerated INH derivative (INHG)].
    Sighart H; Opl G
    Wien Klin Wochenschr; 1969 Nov; 81(46):840-1. PubMed ID: 5380791
    [No Abstract]   [Full Text] [Related]  

  • 16. [On qualitative demonstration of tuberculostatics in the control of taking of drugs].
    Grunert M; Reutgen H; Iwainsky H
    Z Tuberk Erkr Thoraxorg; 1965; 124(3):141-8. PubMed ID: 5899136
    [No Abstract]   [Full Text] [Related]  

  • 17. [Attempt at intermittent chemotherapeutic treatment of patients with bacilli resistant to streptomycin and isoniazid (cooperative survey by the antitubercular services of Marrakech, Meknes, Tangiers)].
    Burzoni FJ; Chicou FJ; Durante C; Hetrick G; Ras R
    Rev Tuberc Pneumol (Paris); 1969 Nov; 33(7):975-86. PubMed ID: 5403000
    [No Abstract]   [Full Text] [Related]  

  • 18. [Results of treatment with a combined 3-drug regimen of secondary drugs in chronic cavernous pulmonary tuberculosis. A study under auspices of the International Union against Tuberculosis].
    Zierski M; Zacara A; Woźniak S
    Gruzlica; 1968 Sep; 36(9):809-18. PubMed ID: 4882450
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical and laboratory experiences with cycloserine.
    Jancík E; Boucková I; Janciková M; Novák M
    Scand J Respir Dis Suppl; 1970; 71():306-13. PubMed ID: 5272001
    [No Abstract]   [Full Text] [Related]  

  • 20. [Primary resistance in adult pulmonary tuberculosis in France. 3d report of the study center on Primary Resistance: 1966-1970].
    Canetti G; Le Lirzin M; Gay P; Thibier R; Kreis B; Grosset J
    Rev Tuberc Pneumol (Paris); 1972; 36(3):337-56. PubMed ID: 5080965
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.